Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing

In his 2015 State of the Union Address, former President Obama announced the Precision Medicine Initiative signaling continued United States government support toward individualized disease detection, prevention, and management strategies 1. Pharmacogenomics is one component of precision medicine and promises to optimize drug therapy through the incorporation of  an individual’s genetic information in drug prescribing decisions. Genotype specifically influences pharmacokinetics and pharmacodynamics and allows for prediction of risk for adverse drug effects and likelihood of drug effectiveness.
Source: Clinics in Laboratory Medicine - Category: Laboratory Medicine Authors: Source Type: research